WO2007108540A1

WO2007108540A1 - Implant tube for injecting body fluid leakage-preventing agent for dead body and apparatus for caring dead body by using the same

Info

Publication number: WO2007108540A1
Application number: PCT/JP2007/056036
Authority: WO
Inventors: Tooru Kojima
Original assignee: Axis International Co., Ltd.
Priority date: 2006-03-23
Filing date: 2007-03-23
Publication date: 2007-09-27
Also published as: JP5119408B2; JP2007254351A

Abstract

An implant tube for injecting a body fluid leakage-preventing agent into a dead body aiming at achieving excellent handling properties and ensuring the convenient injection and loading of the body fluid leakage-preventing agent constantly at a definite application site, which is an implant tube (40) made of a synthetic resin consisting of an implant tube body (40a) having an almost hemispherically closed front end and a plural number of openings (42) in the side face thereof, a connector part (43) located at the back end part of the implant tube body for connecting to a discharge syringe (22) of an injector (10) for the body fluid leakage-preventing agent, and a stopper part (44) projecting outward in the radius direction at a definite position in the implant tube body side of the connector part. In another embodiment mode, the front end of the implant tube body has an almost hemispherical shape formed by a plural number of curved tongue flaps projecting outward toward the radius direction and openings each formed by a slit between the opening and the tongue flap are provided byt the front end of the individual tongue flaps.

Description

Specification

Infusion tube for injecting body fluid leakage prevention agent for corpse and corpse treatment device using the same

Technical field

[0001] The present invention relates to an insertion tube for injecting a bodily fluid leakage preventive agent for preventing leakage of bodily fluid from the corpse by loading and sealing the body cavity of the corpse, particularly the body cavity of the mouth, nose, ear, etc. For

V, related to corpse treatment equipment.

Background art

[0002] In general, after the death of a human animal, muscles in various parts of the body cavity relax, causing bodily fluids such as gastric fluid, lung fluid, ascites, and excreta to leak, which also causes infection by pathogenic bacteria. Yes. For this reason, for example, in hospitals, after confirming death, body cavities such as the mouth, nose, ears, anus, and woman's vagina are loaded with a large amount of gauze, cotton wool, etc. to prevent leakage of bodily fluids. Similar measures are also taken for the opening of the body after an accident or surgery. However, many of the operations for loading gauze and cotton wool into body cavities are often carried out by the hands of employees and nurses. Due to the low water absorption capacity, there was a problem that body fluids often leaked during or after work, and there was a possibility of postmortem infection due to this leaked substance during work, and there was a strong need for a solution.

[0003] Because of this, it is known to load superabsorbent greave powder in the mouth, nose, ears, throat, etc. instead of gauze, absorbent cotton, etc. For example, using a syringe, A method of loading the nose and ear with a highly water-absorbing fat powder (see Patent Document 1: Japanese Patent Application Laid-Open No. 10-298001), and a water-absorbing fat powder containing stable sodium diacid and chlorine are applied to the throat. There is known a method in which the powder is used in the form of a powder and the ear canal and nostril are wrapped in a water-soluble sheet (see Patent Document 2: JP-A-7-265367). However, even when trying to load such a superabsorbent coagulant powder, it is difficult to load into narrow body cavities such as the throat and anus because of poor fluidity. Moreover, if it is only the entrance part of a nostril or an ear canal, such a fine powder can be filled with an injection device such as a syringe, but cannot be filled to the back. Also, inject the syringe to fill If you try to fill it with power, the fine powder coming out from the tip will splatter and force it to just stain the area around the body.

[0004] In order to solve the problems such as poor filling property and workability of such a superabsorbent resin powder and scattering, it has recently been proposed to use a jelly made of powder. In addition, a method of using a powder polymer containing a deodorant dissolved in an appropriate amount of water and mixing appropriately to form a jelly (see Patent Document 3: JP-A-8-133901) or dimethylacrylamide as a main component (Patent Document 4: Japanese Patent Laid-Open No. 2001-288002), and a method in which a large number of superabsorbent polymer powders are dispersed in an alcohol-based jelly (See Patent Document 5: Japanese Patent No. 3586207).

[0005] The filling method in the case of filling such a jelly-like body fluid leakage preventing agent into the throat of the nostril, for example, will be described in Japanese Patent No. 3586207 (Patent Document 5). As shown, the injector 1 containing the jelly-like body fluid leakage preventing agent 2 has an injection port in which the piston 3 is slidably inserted from the rear end portion and the front end thereof is covered with the protective cap 5. 4 and is sealed in a film pack (not shown). The insertion tube 6 to be inserted into a body cavity such as the throat B has a connection part 7 connected to the injection port 4 of the injector 1 at one end and an opening part 8 inserted into the nostril A at the other end. .

[0006] Next, a method of using the corpse treatment apparatus prepared in this way will be described. In Fig. 1, A is the nostril, B is the throat, C is the tongue, D is the trachea, and E is the esophagus. At the time of use, take out the injector 1 from the film pack, remove the protective cap 5 of the inlet 4 of the injector 1, fit the connecting portion 7 of the insertion tube 6 to the inlet 4, and connect the insertion tube 6. Next, the opening 8 of the insertion tube 6 is inserted from the nostril A toward the throat B, and the insertion is stopped when the stopper portion 9 of the insertion tube 6 hits the nose tip B. Then, the piston 3 of the injector 1 is pressed, and the gel-like body fluid leakage preventing agent 2 in the injector 1 is injected into the throat B via the insertion tube 6. After extruding and filling the fluid leakage preventive agent 2 in the injector 1, remove the injector 1 and the insertion tube 6 from the nostril A.

[0007] The jelly-like body fluid leakage preventing agent as described above does not scatter even if it is easily filled and injected with a syringe even in a narrow body cavity such as a nostril or an ear hole having high fluidity. It has the advantages. In particular, in the case of a jelly in which many highly water-absorbing polymer powders are dispersed, the water absorption performance is high. This makes it possible to prevent the body fluid from absorbing body fluid that leaks and preventing it from leaking outside. However, in the case of the combination of the conventional injector and the insertion tube, there is a problem in its operability and there is a mark or stopper portion indicating the insertion stop position in the middle portion of the elongated insertion tube. However, there is a problem that it requires difficulty in inserting the insertion tube, and it is difficult to reliably inject and load the body fluid leakage preventing agent at a constant application site. In addition, since there is an opening at the distal end of the insertion tube, there is a problem if the distal end opening comes into contact with the application site and is blocked, making it difficult to inject the bodily fluid leakage preventing agent.

Patent Document 1: Japanese Patent Laid-Open No. 10-298001

Patent Document 2: Japanese Patent Laid-Open No. 7-265367

Patent Document 3: JP-A-8-133901

Patent Document 4: Japanese Patent Laid-Open No. 2001-288002

Patent Document 5: Japanese Patent No. 3586207

Disclosure of the invention

Problems to be solved by the invention

[0008] Therefore, the object of the present invention is excellent in operability, and without requiring skill in inserting the insertion tube, it is possible to reliably inject and load the body fluid leakage preventing agent with good workability into a constant application site. An object of the present invention is to provide an insertion tube for injecting a body fluid leakage preventing agent for a corpse and a corpse treatment apparatus using the same.

Means for solving the problem

[0009] In order to achieve the above object, according to the present invention, an insertion tube for injecting a bodily fluid leakage preventing agent for a corpse is provided, and a first aspect thereof is a flexible synthetic resin insertion tube. In addition, an insertion tube main body having a front end portion closed in a substantially hemispherical shape and having a plurality of apertures on its side surface, and a body fluid leakage preventing agent injector provided at the rear end portion of the insertion tube main body A connecting portion for connecting to the discharge tube portion, and having a stagger portion protruding radially outward at a predetermined position on the insertion tube main body side of the connecting portion.

[0010] Further, the second aspect is a flexible synthetic resin insertion tube, the tip of which is formed in a substantially hemispherical shape by a plurality of tongue pieces extending outwardly curved toward the radial center. And, at the same time, an opening formed by the ends of the plurality of tongue pieces and a slit between the tongue pieces. An insertion tube main body formed, and a connection portion for connecting to a discharge cylinder portion of a body fluid leakage preventing agent injector provided at a rear end portion of the insertion tube main body, and the insertion tube main body of the connection portion According to a preferred aspect of any of the above, the insertion tube main body is curved at a position separated from the tip by a predetermined distance. Part.

[0011] Further, according to the present invention, the insertion tube for injecting the body fluid leakage preventive agent; and a discharge cylinder portion for connecting to the connection portion of the insertion tube at the tip, and for hooking a finger on the rear end portion A body fluid leakage preventive injector having a cylindrical main body having a flange projecting radially outward and a piston slidably inserted into the cylindrical main body from the rear end side;

V. A corpse treatment device is provided.

In a preferred embodiment, the cylindrical main body of the body fluid leakage preventing agent injector comprises a cylindrical member having a discharge cylinder at the tip and a cover member covered on the outer periphery thereof, and the collar is The cover member is provided, and the piston is slidably inserted into the cylindrical member.

The invention's effect

[0012] According to the first aspect of the insertion tube for injecting a bodily fluid leakage preventing agent for a corpse according to the present invention, the distal end portion of the flexible synthetic resin insertion tube main body is formed in a substantially hemispherical shape. In addition, since the side surface has a plurality of apertures, the insertion tube can be smoothly inserted from the nostril to the throat, and when the tip opening comes into contact with the application site, it is blocked and injected with a body fluid leakage prevention agent. The body fluid leakage preventive agent can be injected and loaded smoothly without problems such as difficulty. Also, it has a connection part for connecting to the discharge cylinder part of the body fluid leakage preventing agent injector provided at the rear end part of the insertion pipe body, and the connection part is arranged in a radial direction at a predetermined position on the insertion pipe body side. Because it has an outer protruding stagger portion, the length between inserts can be shortened compared to the case where a steep flange portion is provided in the middle of the elongated insertion tube, and insertion of the insertion tube is not required for skill. It can be carried out smoothly, and it is possible to inject and load the body fluid leakage preventing agent with the hole portion being surely positioned at a constant application site.

On the other hand, according to the second aspect of the insertion tube for injecting a bodily fluid leakage preventing agent for a corpse according to the present invention. For example, the distal end portion of the flexible synthetic resin insertion tube main body is formed in a substantially hemispherical shape by a plurality of tongue pieces extending outwardly toward the radial center, and the plurality of tongue pieces Since the opening formed by the opening formed by the tip and the slit between the tongue pieces is formed, when the bodily fluid leakage preventing agent filled in the injector is pushed out by the piston, the bodily fluid leakage preventing agent has a plurality of tongue pieces. As it comes out of the slit between the expanded tongue pieces, its surface area increases. Therefore, when it comes into contact with bodily fluid in the body cavity, the liquid is quickly sucked into a solid gel having no fluidity, and it is possible to prevent bodily fluid leakage more effectively and quickly. Also, it has a connection part for connecting to the discharge cylinder part of the body fluid leakage preventing agent injector provided at the rear end part of the insertion pipe body, and this connection part has a radial direction at a predetermined position on the insertion pipe body side. Because it has a protruding strobe part, the length between insertions can be shortened compared to the case where a stubbing part is provided in the middle part of an elongated insertion tube, and the insertion of the insertion tube is smooth without requiring skill. In addition, it is possible to reliably inject and load the bodily fluid leakage preventing agent with the opening portion positioned at a constant application site.

[0014] Further, according to a preferred aspect of the insertion tube for injecting a bodily fluid leakage preventing agent for a corpse, the insertion tube main body has a curved portion at a position a predetermined distance away from the distal end. When inserting to the back of the head, the insertion tube can be inserted smoothly without resistance.

[0015] Furthermore, the treatment apparatus for a corpse of the present invention includes the above-described insertion tube for injecting a bodily fluid leakage preventing agent; a discharge cylinder portion for connecting to the connection portion of the insertion tube at the tip, and a rear end portion. An injector for a body fluid leakage preventing agent having a cylindrical main body having a flange projecting outward in the radial direction for hooking a finger, and a piston slidably inserted into the cylindrical main body at the rear end side. In addition to exerting the effects of using the insertion tube described above, and having a buttocks for hooking a finger to the rear end of the cylindrical main body, injection of a body fluid leakage preventing agent into the body cavity of the corpse The operation can be performed more easily and with good workability.

[0016] Further, according to a preferred aspect of the corpse treatment apparatus, the cylindrical main body of the body fluid leakage preventing agent injector includes a cylindrical member having a discharge cylindrical portion at a tip and a crowned outer periphery thereof. Since the cover is provided on the cover member and the piston is slidably inserted into the cylindrical member, the cost is lower than in the case of integral molding. Can easily manufacture a cylindrical body and the cover member has a polygonal cross section. Or by coloring the cover member or coloring it differently from other members to make it a colorful syringe, so that nurses can easily distinguish between ordinary syringes at the hospital. You can do it, or you can make it clear so that you can see where it is applied. Brief Description of Drawings

FIG. 1 is a schematic cross-sectional view showing a usage state of a conventional body treatment apparatus.

FIG. 2 shows one embodiment of a corpse treatment apparatus according to the present invention, in which (A) is a front view, (B) is a left side view, and (C) is a right side view.

3 is a longitudinal sectional view taken along the central axis of the body treatment apparatus shown in FIG.

4 is a cross-sectional view taken along the central axis of the corpse treatment apparatus shown in FIG.

FIG. 5 is a longitudinal sectional view showing an insertion tube of the corpse treatment apparatus according to the present invention.

FIG. 6 is a partial side view showing another embodiment of the distal end of the insertion tube of the corpse treatment apparatus according to the present invention.

FIG. 7 is a side view showing another embodiment of the insertion tube of the corpse treatment apparatus according to the present invention.

FIG. 8 is a partial cross-sectional view showing still another embodiment of the insertion tube of the corpse treatment apparatus according to the present invention.

Explanation of symbols

1: 10 injector

20 Tubular body

21 Cylindrical member

22 Discharge cylinder

23 Locking part

24 ridge

25 Cover member

26 Buttocks

27 Stubbing section

28 Tongue pieces

29 Protective cap

30 pistons 31 Piston rod

32 Round flange 杳

33 Flange

34 Gasket

35 Disc-shaped part

40 Insertion tube

40a Insertion tube body

42 Openings

43 Connection

45 Tongue

46 Curved part

X Body fluid leakage prevention agent

A nostril

B Throat

C tongue

D trachea

E esophagus

BEST MODE FOR CARRYING OUT THE INVENTION

[0019] The first feature of the insertion tube for injecting a bodily fluid leakage preventing agent according to the present invention is that the distal end portion of the flexible synthetic resin insertion tube body is formed in a substantially hemispherical shape. Thus, the insertion tube can be smoothly inserted from the nostril to the throat. According to the first aspect, since the distal end portion of the insertion tube main body is formed to be closed in a substantially hemispherical shape and has a plurality of apertures on the side surface thereof, it is blocked when the distal end opening comes into contact with the body fluid. The problem of difficulty in injecting the leakage preventive agent can be sufficiently injected.

[0020] On the other hand, in the second aspect, the distal end portion of the insertion tube main body is formed in a substantially hemispherical shape by a plurality of tongue pieces that are curved and extended outward toward the center in the radial direction. An opening formed by an opening formed by the tip of the tongue piece and a slit between the tongue pieces is formed. Therefore, body fluid leakage prevention agent can be sufficiently injected and filled into the injector When the body fluid leakage preventing agent is pushed out by the piston, the body fluid leakage preventing agent pushes out the plurality of tongue pieces and also comes out from the slits between the widened tongue pieces, so that the surface area becomes large. . Therefore, when it comes into contact with the body fluid in the body cavity, an additional effect is obtained that the fluid is quickly sucked into a solid gel having no fluidity, and the body fluid leakage can be prevented more effectively and quickly.

[0021] Further, the second feature common to the insertion pipe for injecting bodily fluid leakage prevention agent according to any of the above aspects is that the discharge cylinder of the bodily fluid leakage prevention agent injector provided at the rear end portion of the insertion tube main body. A connecting portion for connecting to the connecting portion, and a stopper portion protruding radially outward at a predetermined position on the insertion tube main body side of the connecting portion. For this reason, the length between insertions can be shortened compared to the case where a staggered portion is provided in the middle of the elongated insertion tube, the insertion tube can be inserted smoothly without requiring skill, and always constant. The opening portion is surely positioned at the applied site and the body fluid leakage preventing agent can be injected and loaded. Further, when inserting from the nostril to the back of the pharynx, it is preferable to provide a curved portion at a position where the distal end force of the insertion tube main body is separated by a predetermined distance so that the insertion tube can be smoothly inserted without resistance. The insertion tube main body and the connection portion may be integrally formed or may be separate. In the case of a separate body, it is preferable that the connecting portion is formed of a rigid synthetic resin. The connecting portion and the insertion tube main body are joined by an appropriate means such as an adhesive or welding. Further, the stagger portion 44 may be formed at the tip of the connecting portion or may be formed at the intermediate portion of the connecting portion.

[0022] Furthermore, the corpse treatment apparatus of the present invention has a first feature of using the above-described insertion tube for injecting a bodily fluid leakage preventive agent. This is in that it has a flange projecting outward in the radial direction for hooking a finger on the rear end of the cylindrical body. By providing such a buttocks, a finger can be hooked on this, so that the pouring operation is facilitated.

[0023] Furthermore, since the conventional syringe for preventing leakage of body fluid has a similar external shape to a general syringe, there is a possibility that a nurse may mistake the general syringe in a hospital. In the unlikely event that it is mistaken for a general syringe, it will cause a serious medical accident and must be avoided. For that purpose, it is preferable to divide the cylindrical main body of the injector for body fluid leakage preventing agent into a cylindrical member having a discharge cylinder at the tip and a cover member covered by the outer periphery thereof. This makes it one In addition to the advantage that a cylindrical body can be easily manufactured at a lower cost compared to the case of molding, the cover member has a polygonal cross section, the cover member is colored, or the color of the other member is different from that of other members. By coloring it differently from the color and making it a colorful syringe, nurses can easily distinguish it from ordinary syringes in the hospital, or they should be able to grasp the place of application clearly. It is out.

Example

[0024] Hereinafter, specific examples of each aspect of a body fluid leakage preventing agent injection insertion tube and a corpse treatment apparatus using the same according to the present invention will be described with reference to the accompanying drawings.

Figs. 2 to 5 show treatment devices for inserting and loading the fluid leakage preventive agent into the throat by inserting through the nostril. Figs. 2 to 4 show the injector 10 and Fig. 5 shows The insertion tube 40 is shown, and the symbol X indicates the body fluid leakage preventing agent accommodated in the injector 10.

FIGS. 2 to 4 show the injector 10, and FIG. 4 shows a cross-sectional view of the injector 10 rotated from the state shown in FIG. 2 by 90 ° around the center line. As shown in FIGS. 2 to 4, the injector 10 is composed of a cylindrical body 20 and a piston 30, all of which are made of plastic force such as high-density polyethylene, polyester, and polyamide. The cylindrical main body 20 includes a cylindrical member 21 having a discharge cylindrical portion 22 at the tip, and a cover member 25 covered on the outer periphery thereof.

[0026] The cover member 25 is a cylinder having an octagonal cross section as is apparent from FIG. 2, and is configured so that a nurse can easily discriminate it from a general syringe in a hospital, and the distal end side is It is formed in a slightly tapered shape so that it does not easily fall off when the cylindrical member 21 is inserted. It is also possible to make it possible to clearly grasp the place of application by coloring the cover member or coloring it differently from the color of other members to make a colorful injector. As clearly shown in FIG. 4, the cover member 25 has a pair of flange portions 26 protruding outward in the radial direction for hooking a finger to the rear end portion. The distal end portion of the collar portion 26 is curved in the direction of the discharge cylinder portion 22 so that the finger can easily be hooked. It is preferable to set the height of the flange portion 26 from the outer peripheral surface of the cylindrical member 21 to about 5 to 18 mm, and the degree of curvature of the tip portion within a range of 0 to 50 °. Further, a pair of convex locking portions 23 are formed at the rear end of the cylindrical member 21, and when the collar portion 26 comes into contact with the locking portion 23, a finger is bowed on the collar portion 26. And do the injection operation In this case, the cover member 25 is configured not to move rearward from the rear end of the cylindrical member 21. In addition, a protective cap 29 is removably crowned at the distal end opening of the discharge cylinder portion 22 after the body fluid leakage preventing agent of the present invention is filled in the injector 10. In this embodiment, the cylindrical member 21 and the cover member 25 are formed separately, but may be formed as a single body. In addition, the cylindrical member 21 and the cover member 25 may be joined with an adhesive, or at the contact portion of their tip portions, a hole is fitted into one member and the other member is fitted into the hole. Claw portions may be formed and fixed to each other by their engagement.

On the other hand, the piston 30 is slidably inserted into the cylindrical member 21 of the cylindrical main body 20 from the rear end side. The length of the piston 30 is designed to be longer than the length of the cylindrical member 21 so that the entire body fluid leakage preventing agent X in the contents can be pushed out. The piston 30 includes a piston rod 31 having a cross-shaped cross section, and a circular flange portion 32 having a diameter slightly larger than the cross-sectional dimension of the piston rod is formed at the tip of the piston 30. Around the flange portion 33 formed so as to protrude from the circular flange portion 32, a gasket 34 made of synthetic resin or rubber is also covered. In addition, a disc-like portion 35 for touching the finger is formed at the rear end of the piston rod 31 so that the piston rod 31 can be easily pressed with the finger. The piston 30 is formed in the cylindrical member 21 in a state where the gasket 34 is in contact with the inner peripheral surface of the cylindrical member 21 of the injector 10 when a rear end side force is also inserted into the cylindrical member 21 of the cylindrical body 20. It is configured to slide. Furthermore, a ring-shaped ridge 24 protruding slightly inward is formed on the inner peripheral surface in the vicinity of the rear end portion of the cylindrical member 21, and the circular flange portion of the piston rod 31 is formed on the ridge 24. The piston 30 is configured not to easily come out of the cylindrical main body 20 when it hits 32. In this embodiment, the piston rod 31 has a cross-shaped cross section, but may have a rod shape such as a circular cross section.

[0028] The insertion tube 40 is made of a flexible synthetic resin such as a polyester elastomer, a soft chlorinated resin, a rubber, etc., which has the flexibility to rub along the shape of the nasal cavity when inserted into the nostril. As shown in FIG. 5, the insertion tube 40 is composed of an insertion tube body 40a and a connection portion 43, and the distal end portion 41 of the insertion tube body 40a is formed in a substantially hemispherical shape so as to be easily inserted, and is closed. On the side and in two directions shifted in the direction perpendicular to each other. Each has a pair of opening portions 42, and a rearward end portion is provided with a tapered connection portion 43 that is slightly expanded on the rear side for connection to the discharge cylinder portion 22 of the injector 10. ing. Further, at a predetermined position on the insertion tube main body side of the connection portion 43 (preferably the tip position of the connection portion 43), a cross section having a circular cross section protruding outward in the radial direction so as to surround the outer periphery is formed. . The diameter of the stopper portion 44 needs to be sized so as not to be inserted into a desired body cavity such as a nostril.

[0029] The opening 42 at the distal end of the insertion tube 40 can be a hole having a desired shape such as a circle or an ellipse, and the position of the distal end force of the insertion tube is preferably about 5 to 30 mm. . Further, the number of the opening portions 42 may be an arbitrary number of about 2 to 6 forces, which is four in this embodiment. The strobe portion 44 determines the length (injection position) that the opening portion 42 reaches when the insertion tube body is inserted into the pharynx through the nostril. The length to the stagger portion 44 is preferably about 100 to 140 mm, and the outer diameter of the insertion tube body 40a is preferably about 3.5 to 7 mm, and the inner diameter is preferably about 2 to 5 mm.

[0030] When using the above corpse treatment apparatus, first, the protective cap 29 of the discharge tube portion 22 of the injector 10 is removed, and the discharge tube portion 22 is fitted into the connection portion 43 of the insert tube 40 to insert the insert tube 40. And connect the injector 10. Next, the insertion tube body 40a is inserted from the nostril A (see FIG. 1) toward the throat B, and the insertion is stopped when the stopper portion 44 of the insertion tube 40 hits the nose tip. At this time, in order to reduce insertion resistance, a lubricant may be applied to the insertion tube main body 40a. Then, the piston 30 of the injector 10 is pressed, and the jelly-like body fluid leakage preventing agent X in the injector 10 is injected into the throat B through the insertion tube 40. After the body fluid leakage preventing agent X in the injector 10 is extruded and filled, the injector 10 and the insertion tube 40 are extracted from the nostril A. In the above operation method, the insertion tube 40 is inserted into the nostril A while being connected to the injector 10. However, the insertion tube 40 is first inserted into the nostril A, and then the injector 10 is connected to the insertion tube 40. May be.

[0031] Fig. 6 shows a modification of the distal end portion of the insertion tube for injecting a bodily fluid leakage preventing agent according to the present invention.

In this modified example, as shown in FIG. 6, the distal end portion of the insertion tube main body 40a is formed in a substantially hemispherical shape by a plurality of tongue pieces 45 extending outwardly curved toward the center in the radial direction. An opening formed by the tips of the plurality of tongue pieces 45 and a slit between the tongue pieces. A mouth is formed. Each tongue 45 has such flexibility that it can be bent outward. Therefore, when the fluid leakage preventive agent filled in the injector is pushed out by the piston, the fluid leakage preventing agent pushes out the plurality of tongue pieces and also comes out from the slit between the expanded tongue pieces. The surface area becomes large.

FIG. 7 shows another embodiment of the insertion tube for injecting a bodily fluid leakage preventing agent according to the present invention. In this embodiment, the insertion tube main body 40a is curved at a predetermined position from the distal end portion. Except this, it is the same as the insertion tube shown in FIG. By forming such a curved portion 46, when inserting from the nostril to the back of the pharynx, it can be smoothly inserted without resistance. As for the bending position, the distal end force of the insertion tube main body 40a is also preferably about 22 to 45 mm, more preferably any part with a distance of about 20 to 30 mm, and the bending angle is preferably 0 ° to 95 °. More preferably, it is 30 to 70 °.

[0033] In each of the above-described embodiments, the connecting portion 43 is formed as a body at the rear end portion of the insertion tube main body 40a. However, the connecting portion 43 may be a separate body. An example is shown in Fig. 8.

The insertion tube main body 40a and the connection portion 43 are separately prepared in advance, but the rear end portion 47 of the insertion tube main body 40a is inserted into the recessed portion 48 formed at the distal end portion of the connection portion 43, for example, an adhesive, Join by appropriate means such as welding. Thus, when the insertion tube main body 40a and the connection portion 43 are separated, the connection portion 43 is preferably formed of a rigid synthetic resin. In the case of this embodiment, the stopper portion 44 is formed at the tip of the connecting portion 43.

[0034] As a bodily fluid leakage preventive agent that is injected and loaded into a body cavity such as the mouth, nose, and ear of the corpse by the corpse treatment apparatus of the present invention described above, various conventionally known jelly-like bodily fluid leakage preventive agents are used. Particularly preferred is a liquid nonionic surfactant (A) that generates heat when mixed with water and is rapidly soluble in water, and a specific dispersion stabilizer (B It is desirable to use an oil jelly-like body fluid leakage preventing agent obtained by dispersing the superabsorbent coagulant powder (C) in a viscous liquid base containing When such a bodily fluid leakage preventing agent is used, due to the exothermic action of the nonionic surfactant (A) when in contact with bodily fluids, the liquid absorption speed of the superabsorbent resin powder (C) is increased, As a whole, it quickly absorbs and swells the body fluid and solidifies into a solid jelly having no fluidity, thereby effectively preventing leakage of the body fluid. [0035] Nonionic surfactants (A) which are liquid at room temperature include coconut oil fatty acid monoethanolamide, coconut oil fatty acid diethanolamide 1: 1 type, coconut oil fatty acid diethanolamide 1: 2 type, polyoxy Ethylene coconut oil fatty acid monoethanolamide, lauric acid diethanolamide, polyoxyethylene lauryl ether, polyoxyethylene cetyl ether, polyoxyethylene higher alcohol ether, polyethylene glycol (average molecular weight of polymerization degree 600 or less), polyoxyethylene poly Oxypropylene glycol (pull nick type nonionic surfactant with addition of ethylene oxide to polypropylene glycol), polyoxyethylene alkyl (alkyl group having 12 to 14 carbon atoms) ether (number of moles of ethylene oxide attached: 7-12 mol) Polyoxyethylene alkyl ether, sorbitan fatty acid esters, surfactants such as polyoxyethylene sorbitan fatty acid esters and the like, may be used in combination either alone or in combination. Among these nonionic surfactants (A), liquid polyethylene glycol (average molecular weight of the degree of polymerization is about 200 to 600) is preferred! /.

[0036] These liquid nonionic surfactants (A), particularly liquid polyethylene glycol (average molecular weight of the degree of polymerization of about 200 to 600) are the dispersion stabilizer (B) described below, particularly polyalkylene oxide. The thermoplastic non-ionic water-absorbent powder can be easily dissolved at low temperatures (about 30 ° C to 50 ° C), and when mixed with water, it is clear from the following test examples. In addition, when it comes into contact with water, it generates heat and the water temperature rises (increased by about 10 ° C to 12 ° C). Furthermore, since it is a surfactant, it easily mixes and dissolves in water that is compatible with water. As described above, the water-absorbing speed of the highly water-absorbing resin can be increased and quickly solidified into a solid jelly having no fluidity to prevent leakage of body fluids.

[0037] Test example (exothermic temperature measurement test of test material)

Test method:

10 g of each raw material shown in Table 1 was weighed into a 30 ml beaker, and then the exothermic temperature of the mixed solution when 8 g of ion exchange water was injected was measured under the following conditions.

Measuring instrument: DATA COLLECTOR liquid temperature sensor manufactured by Anritsu Keiki Co., Ltd.

Room temperature during measurement: 22.3 ° C.

The test results are also shown in Table 1. [0038] [Table 1]

As shown in Table 1, PEG200, a liquid nonionic surfactant, immediately generated heat when mixed with water, quickly became soluble in water, and maintained its temperature level for some time. . On the other hand, in the case of anhydrous glycerin, ethylene glycol, and ethyl alcohol, which are alcoholic solvents, the ability to generate a slight heat after mixing with water has a fairly low temperature level. Therefore, PEG200, a liquid nonionic surfactant, is a body fluid leakage prevention agent that increases the water absorption rate of highly water-absorbent resin and quickly solidifies into a solid jelly with no fluidity to prevent body fluid leakage. It turns out that it is optimal as a base.

[0039] The content of the nonionic surfactant (A) is preferably about 10 to 85% by mass, more preferably about 20 to 80% by mass, and still more preferably about 10% to 85% by mass of the total amount of the body fluid leakage preventing agent. 30 to 70% by mass. If the content of the non-ionic surfactant (A) exceeds 85% by mass, there will be no problem with the dispersibility of the superabsorbent resin powder, but there will be no jelly-like liquid. The state is not preferable because it is close to an aqueous solution. On the other hand, if the content of the nonionic surfactant (A) is too low, it is difficult to obtain a good jelly state. In addition to the above-described surfactant (A), a surfactant can be contained as needed in a quantitative ratio that does not impair the above-described effects.

[0040] The dispersion stabilizer (B) is intended to maintain a uniform dispersion state of the superabsorbent resin powder, and can absorb various aqueous electrolyte solutions, and is hardly affected by the electrolyte concentration. , Polyalkylene oxide thermoplastic non-ionic water-absorbent resin, carboxybule polymer of acrylic acid copolymer, carboxybule polymer of acrylic acid copolymer 1 Z alkali neutralizer, lipophilic smectite, synthesis At least one selected from group power consisting of hectorite, natural hectorite, and bentonite is used. Among these dispersion stabilizers (B), polyalkylene oxide-based thermoplastic non-one water-absorbing resins are preferable, and these resins can absorb various aqueous electrolyte solutions and are almost influenced by the electrolyte concentration. In addition, it can absorb acid and aqueous alkali solution.

[0041] The content of the dispersion stabilizer (B) is preferably about 0.5 to 40% by mass, more preferably about 1 to 30% by mass, based on the total amount of the body fluid leakage preventing agent. If the content of the dispersion stabilizer (B) is too low, it will be difficult to maintain the uniform dispersibility of the superabsorbent oil-absorbent powder. There is no improvement, and the economic point is favorable.

[0042] As the highly water-absorbent resin powder (C), various kinds of highly water-absorbent resin powders known in the art can be used and are not limited to specific ones. Polyvinyl acrylate, polyacrylate, alginate, cross-linked acrylic acid graft copolymer, copolymer of butyl alcohol and polyacrylic acid, polyethylene glycol polymer, polyacrylamide resin, polyacrylic maleic acid It is possible to suitably use at least one selected from the group consisting of a polymer, a polyethylene oxide polymer, and a polyalginate polymer.

[0043] The superabsorbent resin powder (C) preferably has a mean particle size of about 18 mesh to 160 mesh (according to Tyler display), more preferably about 30 mesh to 140 mesh.

In addition, the content of the superabsorbent rosin powder (C) must be the amount necessary to create a non-flowable gel by immediately absorbing and expanding the body fluid without leaking from the body cavity. . The content of the superabsorbent rosin powder is preferably about 5 to 50% by mass, more preferably about 15 to 35% by mass, based on the total amount of the body fluid leakage preventing agent.

[0044] Further, the body fluid leakage preventing agent further includes water-soluble ethylene glycol, propylene glycol, diethylene glycol, triethylene glycol, glycerin, methinorea nolecore, ethenolenole nolecore as an auxiliary solvent. , Organic solvent (D) such as isopropylenorenoreconole and sodium carboxymethylcellulose for improving fluidity , Carboxymethylcellulose, methenorescenellose, polyvinyl alcohol, polyvinylinol pyrrolidone, sora gum, sodium alginate, and / or other thickeners (E) should be included to facilitate viscosity adjustment and improve fluidity. It is possible to inject and load more smoothly even in narrow body cavities such as the throat. Furthermore, by containing at least one selected from the group consisting of bactericides, fungicides / preservatives, deodorants, and fragrances, these desired effects can also be exhibited.

[0045] The viscosity of the body fluid leakage preventive agent containing each of the above components is preferably about 6,000 to 50, OOOcPs force S, more preferably about ί to have good fluidity. , 000 to 40,000 c Ps.

The viscosity used here is a viscometer (manufactured by Brookfield, USA, “Digital Viscometer” model: DV-1 +), spindle No. 07, rotation speed: 20 rpm, body fluid leakage prevention agent temperature: 20 Force measured at the measurement condition of ° C. If it is a measured value measured under similar conditions, it is not limited to this.

The lower the content of the nonionic surfactant (A), and thus the higher the content of the superabsorbent resin powder (C), the shorter the time it takes for the bodily fluid leakage preventing agent to form a jelly. Moreover, since the viscosity of the liquid rises, by adjusting the blending amount of these liquids, it is possible to adjust the liquid viscosity according to the jelly-like time and the desired application (application site).

[0046] The amount of the bodily fluid leakage preventing agent injected and filled into the body cavity can be appropriately set according to the application site. In addition, the water absorption capability of the highly water-absorbent resin contained in the oil jelly-like body fluid leakage prevention agent is solidified into 3,000 ml of water to prevent water leakage from inside the body cavity. In general, 5 to 60 g is preferable, and 10 to 40 g is more preferable. For example, the filling amount of the bodily fluid leakage preventive agent (containing 5 to 50% by mass of superabsorbent fat) injected into the throat from the nostril of the corpse is preferably about 8 to 40 g, more preferably about 10 to 25 g. If the amount of oil jelly-like body fluid leakage prevention agent injected is too large, the injection device will become large, which will increase the cost of handling. On the other hand, if the injection amount is too small, it becomes difficult to solidify the body fluid into a gel, and there is a risk of the body fluid leaking out, which is not preferable. Industrial applicability

The insertion tube for injecting a bodily fluid leakage preventive agent and the corpse treatment apparatus using the same of the present invention can be easily used for a treatment for preventing body fluid leakage of body cavities, particularly body cavities such as mouth, nose and ear.

Claims

The scope of the claims

[1] A flexible synthetic resin insertion tube, the distal end portion of which is formed in a substantially hemispherical shape, and an insertion tube body having a plurality of apertures on its side surface; And a connecting portion for connecting to the discharge cylinder portion of the body fluid leakage preventing agent injector provided at the end portion, and a stagger portion protruding outward in the radial direction at a predetermined position on the insertion tube main body side of the connecting portion. An insertion tube for injecting a bodily fluid leakage preventing agent for a corpse characterized by comprising:

[2] A flexible synthetic resin insertion tube, the tip portion of which is formed in a substantially hemispherical shape by a plurality of tongue pieces extending outwardly toward the center in the radial direction. An insertion tube main body in which an opening formed by an opening formed by the tip of the tongue piece and a slit between the tongue pieces is formed, and a discharge cylinder of a body fluid leakage preventing agent injector provided at the rear end portion of the insertion tube main body Body fluid leakage prevention, characterized in that it has a connecting portion for connecting to the connecting portion, and has a stagger portion protruding outward in the radial direction at a predetermined position on the insertion tube main body side of the connecting portion. Agent Injection tube.

[3] The insertion tube for injecting a body fluid leakage preventing agent according to claim 1 or 2, wherein the insertion tube main body has a curved portion at a position separated from the tip by a predetermined distance.

[4] The body fluid leakage preventing agent injection insertion tube according to any one of claims 1 to 3; and a discharge tube portion for connecting to a connection portion of the insertion tube at the front end, and a rear end A body fluid leakage preventing agent having a cylindrical main body having a flange protruding outward in the radial direction for hooking a finger on the portion, and a piston which is slidably inserted into the cylindrical main body from the rear end side! A corpse treatment device comprising an infusion device.

[5] The cylindrical main body of the injector for body fluid leakage preventing agent includes a cylindrical member having a discharge cylinder part at the tip and a cover member covered on the outer periphery thereof, and the collar part is the cover member. 5. The treatment device according to claim 4, wherein the piston is slidably inserted into the cylindrical member.